![]() ![]() ![]() President Joe Biden promised early on that his administration would “follow the science,” following disclosures of political meddling in the Trump administration’s coronavirus response. The surprise turn of events could reinforce recent criticism that the Biden administration got out ahead of the science in its push for boosters. ![]() While research suggests immunity levels in those who have been vaccinated wane over time and boosters can reverse that, the Pfizer vaccine is still highly protective against severe illness and death, even amid the delta variant. Scientists inside and outside the government have been divided recently over the need for boosters and who should get them, and the World Health Organization has strongly objected to rich nations giving a third round of shots when poor countries don’t have enough vaccine for their first. Amanda Cohn of the CDC said: “At this moment it is clear that the unvaccinated are driving transmission in the United States.” “And I think it’s important that the main message we transmit is that we’ve got to get everyone two doses.”ĭr. “I don’t think a booster dose is going to significantly contribute to controlling the pandemic,” said Dr. The FDA and CDC will most likely decide at some later point whether people who received the Moderna or J&J shots should get boosters.ĭuring several hours of vigorous debate Friday, members of the panel questioned the value of offering boosters to almost everybody 16 and over. The CDC has said it is considering boosters for older people, nursing home residents and front-line health care workers, rather than all adults. A CDC advisory panel is expected to take up the question on Wednesday. The offering of boosters is also subject to review by the Centers for Disease Control and Prevention. The FDA itself is expected to make a decision on boosters in the next few days, but it usually follows the committee’s recommendations. That would help salvage part of the White House’s campaign but would still be a huge step back from the far-reaching proposal to offer booster shots of both the Pfizer and Moderna vaccines to Americans eight months after they get their second dose.įriday’s ruling was just the first step in the process. population - namely, those most at risk from the virus. Then, in an 18-0 vote, it endorsed the extra shot for select portions of the U.S. Members cited a lack of safety data on extra doses and also raised doubts about the value of mass boosters, rather than ones targeted to specific groups. In a surprising turn, the panel rejected, by a vote of 16-2, boosters for almost everyone. WATCH: FDA holds debate on efficacy of COVID vaccine boosters The ruling came from an influential committee of outside experts who advise the Food and Drug Administration. The twin votes represented a heavy blow to the Biden administration’s sweeping effort, announced a month ago, to shore up nearly all Americans’ protection amid the spread of the highly contagious delta variant. WASHINGTON (AP) - Dealing the White House a stinging setback, a government advisory panel overwhelmingly rejected a plan Friday to give Pfizer COVID-19 booster shots across the board, and instead endorsed the extra vaccine dose only for those who are 65 or older or run a high risk of severe disease. ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |